02.07.2024 11:26:02 - Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech

===
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
02-Jul-2024 / 11:25 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


Aubagne, July 2nd, 2024

Half-year liquidity contract statement for Sartorius Stedim Biotech

Under the liquidity contract entered into between Sartorius Stedim Biotech and Kepler Cheuvreux, the following
resources appeared on the liquidity account on June 30th 2024:

? 46,292 shares
? EUR 2,521,189.91
? Number of executions on buy side on semester: 6,493
? Number of executions on sell side on semester: 5,322
? Traded volume on buy side on semester: 305,402 shares for EUR 69,412,550.00
? Traded volume on sell side on semester: 273,281 shares for EUR 63,664,027.43

As a reminder :

The following resources appeared on the last half year statement on 31 December 2023 on the liquidity account:

? 14,171 shares
? EUR 8,132,662.14
? Number of executions on buy side on semester: 5,238
? Number of executions on sell side on semester: 4,912
? Traded volume on buy side on semester: 230,377 shares for EUR 50,832,014.40
? Traded volume on sell side on semester: 239,123 shares for EUR 54,101,099.12

The following resources appeared on the liquidity account when the activity started:

? 0 shares
? EUR 10,000,000.00


The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing
the implementation of liquidity contracts for shares as an accepted market practice.
A profile of Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a provider of
innovative solutions, the company based in Aubagne, France, helps its customers to manufacture biotech medications,
such as cell and gene therapies, safely, rapidly, and economically. The shares of Sartorius Stedim Biotech S.A. are
quoted on the Euronext Paris. The company has a strong global reach with manufacturing and R&D sites as well as sales
entities in Europe, North America, and Asia. Sartorius Stedim Biotech regularly expands its portfolio through
acquisitions of complementary technologies. In 2023, the company generated sales revenue of around 2.8 billion euros.
Currently, more than 10,600 employees are working for customers around the globe.

Contact
Petra Müller
Head of Investor Relations
+49 (0)551.308.6035
Petra.mueller2@sartorius.com

Sartorius Stedim Biotech S.A.
Z.I. Les Paluds
Avenue de Jouques, CS 91051
13781 Aubagne Cedex, France
Phone: +33.(0)4.42.84.56.00
Fax: +33.(0)4.42.84.56.19
www.sartorius.com



Buy side                                             Sell side 
Number of          Number of      Traded volume in   Number of          Number of      Traded volume in 
executions         shares         EUR                executions         shares         EUR 
Total         6,493              305,402        69,412,550.00      5,322              273,281        63,664,027.43 
01/02/2024    16                 1,000          244,350.00         107                4,495          1,109,725.60 
01/03/2024    82                 3,428          839,277.24         28                 1,600          393,104.00 
01/04/2024    91                 3,592          864,342.96         41                 1,662          404,397.84 
01/05/2024    103                3,499          818,731.01         54                 2,800          660,492.00 
01/08/2024    92                 3,350          786,881.50         47                 2,500          590,150.00 
01/09/2024    33                 1,700          403,546.00         36                 2,300          550,390.00 
01/10/2024    85                 3,800          912,152.00         44                 1,901          460,346.16 
01/11/2024    74                 3,350          793,816.00         50                 2,601          620,234.46 
01/12/2024    65                 3,500          821,065.00         59                 2,600          616,070.00 
01/15/2024    54                 1,900          440,952.00         31                 1,611          374,879.70 
01/16/2024    165                4,500          1,004,760.00       32                 1,900          427,994.00 
01/17/2024    62                 2,700          600,723.00         41                 1,400          313,026.00 
01/18/2024    54                 2,400          533,784.00         37                 1,800          403,704.00 
01/19/2024    35                 1,991          433,878.72         47                 2,600          570,908.00 
01/22/2024    41                 1,700          378,658.00         63                 2,500          559,900.00 
01/23/2024    55                 2,540          565,683.40         46                 2,225          497,376.50 
01/24/2024    71                 3,300          740,487.00         72                 3,176          716,473.84 
01/25/2024    48                 2,470          551,872.10         86                 4,009          903,548.42 
01/26/2024    54                 2,605          614,884.20         125                6,725          1,618,976.50 
01/29/2024    65                 3,303          788,591.25         47                 2,826          680,755.14 
01/30/2024    108                5,073          1,186,879.08       83                 4,604          1,103,716.92 
01/31/2024    -                  -              -                  84                 4,599          1,135,171.17 
02/01/2024    58                 2,675          663,186.00         29                 1,423          354,711.21 
02/02/2024    85                 4,200          1,036,182.00       55                 1,777          444,392.16 
02/05/2024    43                 1,700          411,400.00         55                 3,002          732,217.82 
02/06/2024    44                 2,140          525,669.60         50                 2,500          619,550.00 
02/07/2024    91                 4,300          1,051,436.00       56                 3,500          880,390.00 
02/08/2024    83                 3,700          947,681.00         96                 4,500          1,172,115.00 
02/09/2024    67                 3,700          930,624.00         71                 3,700          936,729.00 
02/12/2024    79                 4,101          1,015,899.72       29                 1,600          401,152.00 
02/13/2024    77                 3,821          921,816.25         29                 1,600          388,464.00 
02/14/2024    54                 2,247          536,740.89         46                 2,509          601,733.47 
02/15/2024    40                 1,860          449,692.20         68                 2,891          702,137.17 
02/16/2024    13                 500            123,700.00         84                 4,400          1,098,900.00 
02/19/2024    41                 2,313          579,221.46         60                 3,000          757,890.00 
02/20/2024    56                 2,987          750,722.71         8                  403            102,108.11 
02/21/2024    82                 4,100          1,010,937.00       35                 1,700          426,955.00 
02/22/2024    25                 1,102          279,059.46         79                 3,812          969,505.96 
02/23/2024    55                 2,448          612,979.20         21                 900            225,846.00 
02/26/2024    60                 3,098          767,033.82         13                 900            225,099.00 
02/27/2024    34                 2,200          543,840.00         45                 2,700          670,707.00 
02/28/2024    18                 1,217          303,483.29         39                 2,200          550,880.00 
02/29/2024    21                 1,024          259,307.52         85                 3,585          912,633.45 
03/01/2024    62                 3,859          965,598.98         29                 1,800          454,140.00 
03/04/2024    41                 2,200          551,694.00         29                 1,500          377,325.00 
03/05/2024    40                 2,000          498,900.00         52                 2,700          677,403.00 
Buy side                                             Sell side 
Number of          Number of      Traded volume in   Number of          Number of      Traded volume in 
executions         shares         EUR                executions         shares         EUR 
Total         6,493              305,402        69,412,550.00      5,322              273,281        63,664,027.43 
03/06/2024    17                 955            241,777.35         67                 3,800          967,784.00 
03/07/2024    7                  512            132,469.76         88                 4,400          1,152,800.00 
03/08/2024    -                  -              -                  50                 2,400          645,912.00 
03/11/2024    70                 3,152          847,856.48         59                 2,700          730,269.00 
03/12/2024    38                 1,950          528,430.50         57                 2,800          764,092.00 
03/13/2024    66                 3,400          922,794.00         36                 2,159          590,054.70 
03/14/2024    23                 1,800          496,152.00         74                 3,442          951,850.68 
03/15/2024    80                 4,440          1,217,670.00       32                 1,904          524,456.80 
03/18/2024    88                 3,908          1,053,557.72       14                 900            246,447.00 
03/19/2024    55                 2,351          617,983.86         45                 2,300          607,016.00 

===
(MORE TO FOLLOW) Dow Jones Newswires

July 02, 2024 05:26 ET (09:26 GMT)
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
SARTOR.STED.B. EO-,20 A2AJKS Frankfurt 153,850 04.07.24 08:01:10 +1,300 +0,85% 154,350 155,550 153,850 152,550

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH